Featured

The Economics of a Longevity Dividend



Published
The growing emphasis on and progress in extending biological and “healthy” aging raises a number of important questions for health scientists and economists alike. Is it preferable to make lives healthier by compressing morbidity, or to make lives longer by extending life? What are the gains from targeting aging itself compared with efforts to eradicate specific diseases? Economist Andrew J. Scott, coauthor of The Economic Value of Targeting Aging, will share findings and implications from the publication. This public policy webinar from The Gerontological Society of America aims to draw awareness to the many ways geroscience intersects across all disciplines as well as impacts policy.

Presented by:

Andrew J. Scott, DPhil, Professor of Economics, Consulting Scholar, Stanford University Center on Longevity, and Research Fellow at the Centre for Economic Policy Research
George E. Taffet, MD, FACP, Professor in Medicine, Geriatrics, and Cardiovascular Sciences and the Robert J. Luchi, MD, Chair in Geriatric Medicine, Baylor College of Medicine; Head of the Division of Geriatrics, Houston Methodist Hospital; 2022 Chair, GSA Public Policy Advisory Panel (Moderator)

This webinar was developed by the 2022 GSA Public Policy Advisory Panel.
Category
Health
Be the first to comment